Pensionfund Sabic Buys Shares of 2,300 McKesson Corporation $MCK

Pensionfund Sabic purchased a new position in McKesson Corporation (NYSE:MCK) in the fourth quarter, Holdings Channel reports. The fund purchased 2,300 shares of the company’s stock, valued at approximately $1,887,000.

Other large investors also recently made changes to their positions in the company. Brighton Jones LLC grew its position in shares of McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after purchasing an additional 798 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of McKesson during the 1st quarter worth about $233,000. Sivia Capital Partners LLC lifted its position in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after purchasing an additional 300 shares during the last quarter. American Century Companies Inc. boosted its stake in McKesson by 16.0% during the 2nd quarter. American Century Companies Inc. now owns 13,718 shares of the company’s stock valued at $10,052,000 after purchasing an additional 1,895 shares during the period. Finally, Waterloo Capital L.P. boosted its stake in McKesson by 40.6% during the 2nd quarter. Waterloo Capital L.P. now owns 782 shares of the company’s stock valued at $573,000 after purchasing an additional 226 shares during the period. Institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other news, Director Maria Martinez sold 349 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director owned 301 shares in the company, valued at approximately $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 3,868 shares of company stock valued at $3,743,820. Insiders own 0.08% of the company’s stock.

McKesson Trading Up 0.5%

Shares of McKesson stock opened at $881.01 on Wednesday. The stock has a market capitalization of $107.91 billion, a price-to-earnings ratio of 25.34, a P/E/G ratio of 1.41 and a beta of 0.38. The firm’s 50-day moving average price is $905.89 and its two-hundred day moving average price is $837.19. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts predict that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Wells Fargo & Company lifted their price target on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. Morgan Stanley reaffirmed an “overweight” rating and set a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. TD Cowen increased their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Finally, Raymond James Financial set a $970.00 price target on McKesson in a report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, McKesson presently has an average rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.